Global Negative Pressure Wound Therapy (NPWT) Market Size, Share, Forecast Report, 2020-2027

Negative Pressure Wound Therapy (NPWT) devices are used to treat chronic wounds, such as diabetic ulcers, pressure sores, and post-operative wounds, through the application of sub-atmospheric pressure to an open wound. Growing prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and high rate of cesarean sections in elderly mothers leading to increasing post-operative use of NPWT devices are some of the factors expected to drive market growth during the forecast period.

The negative pressure wound therapy market is expected to reach USD 2, 724.2 million by 2023, from USD 2,113.6 million in 2018, at a CAGR of 5.2%. This market is segmented by product type, wound type, end-user, and region. The base year for this study is 2017, and the forecast period is 2018–2023.

By product type, conventional NPWT devices segment is expected to account for the largest market share during the forecast period
Based on products, the NPWT devices market is segmented into conventional NPWT devices, single-use NPWT devices, and accessories. In 2018, the conventional NPWT devices segment was expected to account for the largest market share during the forecast period. This segment is driven by the ability of conventional NPWT systems to manage severe wound exudates. However, high costs and the growing adoption of disposable NPWT devices are restraining market growth to a certain extent.
By wound type, the surgical & traumatic wounds segment is expected to dominate the negative pressure wound therapy market
Based on wound type, the NPWT devices market is segmented into surgical & traumatic wounds, ulcers, and burns. In 2018, the surgical & traumatic wounds segment was expected to account for the largest share of the NPWT devices market. This growth can be attributed to the growing prevalence of surgical & traumatic wounds and increasing spending on chronic and surgical wounds.

North America to command the negative wound pressure market during the forecast period
Based on region, the NPWT devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2017, North America commanded the largest share of the NPWT devices market. The large share of this market segment can be attributed to the increasing incidence of chronic wounds and diabetes and rising geriatric population. In addition to this, a favorable reimbursement scenario is expected to increase the adoption of NPWT devices in this regional segment.

The major players operating in this market are Acelity (US), Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health (US), ConvaTec (UK), DeRoyal (US), Lohmann & Rauscher (German), Talley Group (UK), Medela (Switzerland), and Genadyne (US).
Market Dynamics
Driver: Growing prevalence of diabetes
The rising prevalence of diabetes across the globe is a major factor contributing to the growth of the negative pressure wound therapy (NPWT) devices market. The number of people suffering from diabetes globally is expected to reach 642.0 million by 2040 from 415.0 million in 2015, as estimated by the International Diabetes Federation (IDF).

Diabetes and related ulcers (including diabetic foot ulcers, venous ulcers, and pressure ulcers), traumatic wounds, and surgical wounds need effective and intense care for healing. Various prophylactic devices such as disposable, standalone, and portable NPWT devices enable faster and more effective recovery of these conditions. Generally, infections of the main compartments and abscesses can be drained by incisions. As incisions on the plantar surface heal slowly, this leads to a lengthier period of immobilization. This will stimulate the demand for advanced wound management for drainage and faster healing of wounds, which in turn will boost the demand for NPWT devices.

Trend: Growing usage of simplified single-use devices
Hospital-based NPWT devices are increasingly being used for the delivery of additional therapies such as saline irrigation/instillation, either intermittently or continuously with NPWT. The benefits of powerful antimicrobial solutions for wounds with a high bioburden are under investigation. In addition to this, the delivery of alternative active substances such as insulin or doxycycline is being investigated, yet on a non-commercial (off label-use) basis.

On the other hand, there is a substantial development in the use of simplified single-use NPWT devices. This change, which includes both electrically powered and mechanically powered devices, has made NPWT devices more accessible to end-users as well as more economical. This permits the widespread adoption of single-use devices to reduce complications such as SSIs. Also, single-use devices do not restrict patient mobility as they are portable, smaller in dimension, and are self-contained.

Technological developments in NPWT have already led to expansions in their indications. For example, smaller, single-use disposable pumps can now treat new types of wounds (small, surgical wounds) in-home care settings. Adding to this, the new interventions underway may even further contribute to the increased uptake of NPWT devices.

This report categorizes the negative pressure wound therapy market into the following segments and sub-segments:

By Product Type

• Conventional NPWT Devices
• Single-use NPWT Devices
• Accessories

By Wound Type

• Surgical and Traumatic Wounds
• Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Diabetic Foot Ulcers
  • Other Ulcers
• Burns

By End-User

• Hospitals
• Home Care Settings
• Other End Users

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Rest of Europe
• Asia
  • Japan
  • China
  • India
  • Rest of Asia
• Rest of the World